Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $51M invested in Invesco Biotechnology & Genome ETF in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
42% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 24
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
73
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.54M | |
| 2 | +$625K | |
| 3 | +$560K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$461K |
| 5 |
Jane Street
New York
|
+$308K |
Top Sellers
| 1 | -$4.08M | |
| 2 | -$3.17M | |
| 3 | -$1.28M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.19M |
| 5 |
Morgan Stanley
New York
|
-$848K |